Related Experiment Video
Updated: Jun 10, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Design of clinical trials
David Rollo1, Sanjay Machado, Mauro Ceschin
1Cell>Point LLC, Centennial, CO 80111, USA. david.rollo@cellpointweb.com
Seminars in Nuclear Medicine
|August 3, 2010
Summary
Designing clinical trials for nuclear medicine diagnostic imaging radiopharmaceuticals requires rigorous preclinical safety and human biodistribution studies. Equivalence or noninferiority trials, adhering to Good Clinical Practice (GCP), ensure unbiased efficacy validation against comparators.
Area of Science:
- Nuclear medicine
- Radiopharmaceutical development
- Clinical trial design
Background:
- Preclinical safety studies are essential for investigational products (IPs) in nuclear medicine.
- Phase 1 human studies assess biodistribution, pharmacokinetics, and radiation dosimetry for regulatory approval.
- Late-phase trials (Phase 2/3) validate clinical efficacy in diagnosed patients.
Purpose of the Study:
- To outline essential components of clinical trial design for diagnostic imaging radiopharmaceuticals.
- To emphasize the importance of safety, biodistribution, and efficacy validation.
- To describe the common use of equivalence or noninferiority trials.
Main Methods:
- Preclinical toxicology assessments.
- Phase 1 human studies for safety and biodistribution.
- Equivalence or noninferiority trial designs comparing new IPs to standard comparators.
- Use of independent core laboratories to mitigate bias in image interpretation.
- Adherence to Good Clinical Practice (GCP) guidelines throughout the trial process.
Main Results:
- Successful completion of safety and biodistribution studies enables progression to late-phase trials.
- Equivalence/noninferiority trials aim to demonstrate comparable efficacy to established agents.
- Objective image scoring by independent core labs ensures unbiased results.
- GCP compliance ensures standardized and ethical trial conduct.
Conclusions:
- Robust clinical trial design is critical for the approval of nuclear medicine diagnostic agents.
- Demonstrating safety and comparable efficacy through well-designed trials is paramount.
- Adherence to GCP and unbiased methodologies ensures reliable validation of diagnostic imaging radiopharmaceuticals.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...